Tsai MY - Search Results

1

Molecular and biochemical approaches in the identification of heterozygotes for homocystinuria.

Tsai MY, Garg U, Key NS, Hanson NQ, Suh A, Schwichtenberg K. Tsai MY, et al. Atherosclerosis. 1996 Apr 26;122(1):69-77. doi: 10.1016/0021-9150(95)05748-x. Atherosclerosis. 1996. PMID: 8724113

2

Effects of fluvastatin (XU 62-320), an HMG-CoA reductase inhibitor, on the distribution and composition of low density lipoprotein subspecies in humans.

Yuan JN, Tsai MY, Hegland J, Hunninghake DB. Yuan JN, et al. Among authors: tsai my. Atherosclerosis. 1991 Apr;87(2-3):147-57. doi: 10.1016/0021-9150(91)90017-w. Atherosclerosis. 1991. PMID: 1854361 Clinical Trial.

3

The occurrence of phenylketonuria and galactosemia within the same family.

Fisch RO, Goosens KA, Tsai MY, Seelig S, Schwichtenberg K. Fisch RO, et al. Among authors: tsai my. Clin Pediatr (Phila). 1985 Aug;24(8):456-8. doi: 10.1177/000992288502400808. Clin Pediatr (Phila). 1985. PMID: 4006356 No abstract available.

4

Amplification refractory mutation system to identify mutations in cystathionine beta-synthase deficiency.

Tsai MY, Hanson NQ, Schwichtenberg K, Garg U. Tsai MY, et al. Clin Chem. 1995 Dec;41(12 Pt 1):1775-7. Clin Chem. 1995. PMID: 7497621 No abstract available.

5

Single-strand conformational polymorphisms (SSCP): studies of the genetic polymorphisms of exon 4 of apolipoprotein C III.

Beheshti I, Hanson NQ, Copeland KR, Garg U, Tsai MY. Beheshti I, et al. Among authors: tsai my. Clin Biochem. 1995 Jun;28(3):303-7. doi: 10.1016/0009-9120(94)00083-8. Clin Biochem. 1995. PMID: 7554250

6

Tyrosinase inhibition due to interaction of homocyst(e)ine with copper: the mechanism for reversible hypopigmentation in homocystinuria due to cystathionine beta-synthase deficiency.

Reish O, Townsend D, Berry SA, Tsai MY, King RA. Reish O, et al. Among authors: tsai my. Am J Hum Genet. 1995 Jul;57(1):127-32. Am J Hum Genet. 1995. PMID: 7611281 Free PMC article.

7

Changes in composition and distribution of LDL subspecies in hypertriglyceridemic and hypercholesterolemic patients during gemfibrozil therapy.

Yuan J, Tsai MY, Hunninghake DB. Yuan J, et al. Among authors: tsai my. Atherosclerosis. 1994 Sep 30;110(1):1-11. doi: 10.1016/0021-9150(94)90062-0. Atherosclerosis. 1994. PMID: 7857363 Clinical Trial.

8

Determination of a T/G polymorphism at nucleotide 3206 of the apolipoprotein C III gene by amplification refractory mutation system.

Tsai MY, Hanson NQ, Copeland KR, Beheshti I, Garg U. Tsai MY, et al. Clin Chem. 1994 Dec;40(12):2235-9. Clin Chem. 1994. PMID: 7988011

9

Determination of apolipoprotein E genotypes by single-strand conformational polymorphism.

Tsai MY, Suess P, Schwichtenberg K, Eckfeldt JH, Yuan J, Tuchman M, Hunninghake D. Tsai MY, et al. Clin Chem. 1993 Oct;39(10):2121-4. Clin Chem. 1993. PMID: 8403396

10

Laboratory diagnosis of medium-chain acyl-coenzyme A dehydrogenase deficiency by the amplification refractory mutation system.

Tsai MY, Schwichtenberg K, Tuchman M. Tsai MY, et al. Clin Chem. 1993 Feb;39(2):280-3. Clin Chem. 1993. PMID: 8432018

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

817 results

Search Page

Filters